Lamotrigin Axcount

Lamotrigine, the active ingredient in Lamotrigin Axcount, is an Anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of epilepsy, for mood stabilization in bipolar disorder, and for the prevention of migraine in adult patients.

GNH USA supplies Lamotrigin Axcount as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from comprehensive regulatory support and timely delivery across multiple continents.

Lamotrigine is used in several neurological and psychiatric conditions that involve abnormal neuronal excitability.

Epilepsy: reduces seizure frequency by stabilizing neuronal membranes and limiting excessive firing. Bipolar disorder: provides mood stabilization by decreasing rapid mood swings and depressive episodes. Migraine prevention: lowers the occurrence of migraine attacks through modulation of cortical excitability. Adjunct therapy: may be combined with other antiepileptic drugs to improve seizure control.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Skin rash: mild erythema or itching that may appear on the trunk or limbs. - Dizziness: sensation of light‑headedness, often accompanied by unsteadiness. - Headache: mild to moderate pressure or throbbing pain, sometimes worsened by stress. - Nausea: occasional stomach upset, sometimes with a transient loss of appetite. - Fatigue: generalized tiredness that can affect daily activities. - Visual disturbances: blurred vision or transient visual flickers.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering, mucosal involvement, and fever. - Aseptic meningitis: sudden onset of fever, neck stiffness, headache, and photophobia. - Blood dyscrasias: agranulocytosis, leukopenia, or pancytopenia requiring immediate medical attention. - Severe hypersensitivity: anaphylaxis, angioedema, or swelling of the face and throat. - Hepatotoxicity: abnormal liver function tests or jaundice. - Suicidal ideation: emergence of depressive thoughts or suicidal behavior.

Lamotrigine requires careful monitoring and specific safety measures.

Dose titration: increase gradually under medical supervision to reduce rash risk. Skin monitoring: discontinue immediately if a rash develops, especially facial or widespread. Renal impairment: adjust dose in patients with reduced kidney function. Concomitant valproate: be aware of increased lamotrigine levels and adjust dosing. Pregnancy: discuss risks and benefits with a healthcare provider. Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels; avoid co‑administration without dose reduction. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenobarbital: induces metabolism leading to lower lamotrigine exposure. - Phenytoin: accelerates clearance, requiring careful monitoring. - Oral contraceptives: may lower lamotrigine levels, risking loss of seizure control.

Moderate Interactions (Monitor Closely): - Serotonergic agents: potential for serotonin syndrome; monitor for agitation, tremor, or hyperreflexia. - Other antiepileptics (e.g., levetiracetam): may require dose adjustments based on seizure control. - Antidepressants (e.g., SSRIs): observe for increased side‑effects such as dizziness. - Immunosuppressants (e.g., azathioprine): monitor blood counts for hematologic effects. - Alcohol: may enhance dizziness and sedation; advise moderation.